Newsroom

Sorted by: Latest

-

GE HealthCare Announces First Patient Dosed in Phase 2/3 LUMINA Trial for Manganese-Based MRI Contrast Agent Under FDA Fast Track Designation, Further Advancing Its Innovation Pipeline of Novel Imaging Agents

CHALFONT ST GILES, England--(BUSINESS WIRE)--GE HealthCare announces first patient dosed in Phase 2/3 LUMINA trial for manganese-based MRI contrast agent under FDA Fast Track designation...
-

Sanborn Achieves SOC 2 Type 2 Attestation for Second Consecutive Year, Expanding Scope Across Private Cloud and Google Cloud (GCP)

COLORADO SPRINGS, Colo.--(BUSINESS WIRE)--Sanborn, a leader in geospatial solutions, is proud to announce it has successfully completed its SOC 2 Type 2 audit for the second year in a row....
-

Omni Raises Series C at $1.5B Valuation, Building the AI Analytics Platform for the Enterprise

SAN FRANCISCO--(BUSINESS WIRE)--Omni, the AI Analytics platform, today announced its Series C funding round raising $120M at a $1.5B valuation, led by ICONIQ with participation from existing investors Theory Ventures, First Round Capital, Redpoint Ventures, and GV. The round includes a $30M employee tender offer. The round marks a significant step-up from Omni's previous $650M valuation in March 2025, driven by 4x year-over-year revenue growth from companies consolidating legacy BI use cases, a...
-

Mobileye Releases First Quarter 2026 Results, Updates Full-Year Outlook, and Announces a $250 Million Share Repurchase Program

JERUSALEM--(BUSINESS WIRE)--Mobileye Global Inc. (Nasdaq: MBLY) (“Mobileye”) today released its financial results for the three months ended March 28, 2026. “First quarter results reflected a stronger than expected start to 2026, and continued favorable demand trends enable us to modestly increase our 2026 outlook. We also secured an important design win with Mahindra which adds a third Surround ADAS customer and a second customer for our next-generation SuperVision product,” said Mobileye Pres...
-

Croma Pharma Launches AI-Driven Tech Venture to Revolutionize Aesthetic Medicine via Clinicore Platform

LEOBENDORF, Austria--(BUSINESS WIRE)--Croma Pharma has launched a strategic joint venture to accelerate the development of Clinicore, its premium digital solution for aesthetic practices. This dedicated entity will focus on scaling the next generation of the platform while ensuring full continuity for existing users. Clinicore: Elevating Practice Excellence through AI Clinicore is a specialized SaaS (Software as a Service) solution designed to optimize the daily operations of aesthetic clinics....
-

Ironwood Pharmaceuticals to Share Real-World HCP Perspectives on Burden of Total Parenteral Nutrition in Short Bowel Syndrome (SBS) at Digestive Disease Week® 2026

BOSTON--(BUSINESS WIRE)--Ironwood Pharmaceuticals, Inc. (Nasdaq: IRWD), a biotechnology company developing and commercializing life-changing therapies for people living with gastrointestinal (GI) and rare diseases, announced today that the company will present data from its LANDMARK survey during the 2026 Digestive Disease Week® (DDW) meeting being held from May 2-5 in Chicago, IL. The data will spotlight healthcare professional (HCP) insights on the burden of total parenteral nutrition (TPN) f...
-

NeoGenomics Expands Access to Full Oncology Testing Portfolio Through Epic Aura Integration

FORT MYERS, Fla.--(BUSINESS WIRE)--NeoGenomics' oncology testing portfolio is now available through Epic Aura....
-

El director ejecutivo de Avangrid, José Antonio Miranda, participó en la Cumbre de Energía de la Cámara de Comercio Hispana de Estados Unidos

SANTA FE, N.M.--(BUSINESS WIRE)--Avangrid, Inc., una de las principales empresas energéticas de Estados Unidos y miembro del Grupo Iberdrola, anunció que su director ejecutivo, José Antonio Miranda, participó del debate sobre el desafío persistente de la asequibilidad energética durante la Cumbre de Energía 2026 de la Cámara de Comercio Hispana de Estados Unidos (USHCC), realizada del 20 al 22 de abril en Santa Fe, Nuevo México. “Las inversiones estratégicas en infraestructura son la manera de...
-

Dynamo University Boston 2026 Announced: Mastering AI-powered Workflows and the Future of Tech-enabled Alternative Investments

BOSTON--(BUSINESS WIRE)--Dynamo University Boston for private investment ALTs professionals is scheduled for May 14 & May 15, 2026, at the Westin Copley Place, Boston....
-

American Express Reports First-Quarter 2026 Financial Results

NEW YORK--(BUSINESS WIRE)--American Express Company (NYSE: AXP) today reported its first-quarter 2026 financial results. The earnings release and supplemental financial data are available on the company’s Investor Relations website at http://ir.americanexpress.com. An investor conference call will be held at 8:30 a.m. (ET) today to discuss the company’s first-quarter 2026 results. Live audio and presentation slides for the investor conference call will be available to the general public on the...